3.
受试者临床指标特征
Clinical data and SPP of RA patients
| Clinical index | HC (n=30) | RA (n=50) | P |
| RF (U/mL) | 7.88±2.97 | 109.70(46.13, 233.63) | ＜0.01 |
| ESR (mm/h) | 5.20(3.27, 8.92) | 37.50(28.25, 64.00) | ＜0.01 |
| anti-CCP (U/mL) | 2.88±1.06 | 86.05(33.38, 270.50) | ＜0.01 |
| hs-CRP (mg/L) | 1.47±1.03 | 9.86(2.42, 43.42) | ＜0.01 |
| IgA (g/L) | 1.32±0.67 | 2.69(1.97, 3.63) | ＜0.01 |
| IgG (g/L) | 8.39±2.24 | 9.76(8.42, 12.52) | ＜0.01 |
| IgM (g/L) | 1.51±0.50 | 1.25(1.08, 1.72) | 0.141 |
| C3 (g/L) | 1.08±0.24 | 1.14(0.99, 1.35) | 0.154 |
| C4 (g/L) | 0.27±0.09 | 0.31(0.25, 0.39) | 0.141 |
| DAS-28 | - | 4.75(3.70, 5.60) | - |
| SAS | - | 52.50(43.94, 60.31) | - |
| SDS | - | 56.88(44.56, 66.25) | - |